Ocular Therapeutix OCUL Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's accrued expenses?
- Ocular Therapeutix (OCUL) reported accrued expenses of $36.49M in Q1 2026.
- How has Ocular Therapeutix's accrued expenses changed year-over-year?
- Ocular Therapeutix's accrued expenses increased by 17.4% year-over-year, from $31.08M to $36.49M.
- What is the long-term trend for Ocular Therapeutix's accrued expenses?
- Over 5 years (2020 to 2025), Ocular Therapeutix's accrued expenses has grown at a 25.1% compound annual growth rate (CAGR), from $14.31M to $43.84M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.